Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma
Status:
Not yet recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
This study is to investigate the efficacy and safety of the induction chemotherapy +
concurrent chemoradiotherapy（CCRT）combined with toripalimab and endostar treatment, in
comparison with the induction chemotherapy + concurrent chemoradiotherapy（CCRT）, in treating
locally advanced high-risk nasopharyngeal carcinoma
Phase:
Phase 2
Details
Lead Sponsor:
First Affiliated Hospital of Guangxi Medical University
Collaborators:
Affiliated Hospital of North Sichuan Medical College Fourth Affiliated Hospital of Guangxi Medical University Guilin Medical College Jiangxi Provincial Cancer Hospital LiuZhou People's Hospital Shandong Cancer Hospital and Institute The Affiliated Hospital Of Guizhou Medical University Wuhan Union Hospital, China Xiangya Hospital of Central South University Zhejiang Cancer Hospital